Impact of known baseline risk factors of RP on total PsA-modified vdH-S scores through Week 100
PsA, der Heijde-Sharp
PSORIATIC ARTHRITIS, DISEASE
In all models, elevated baseline CRP concentration and higher baseline PsA-modified vdH-S score were significantly associated with greater RP through Week 100 (CRP β range: 0.17–0.18, vdH-S score β = 0.02) (Table Multivariate association of DAPSA improvement at Week 8 and known baseline risk factors of radiographic progression with change in total PsA-modified vdH-S score through Week 100 among patients randomized to receive guselkumab Q4W or Q8W (CRP = C-reactive protein; DAPSA = Disease Activity Index for PsA; PsA = psoriatic arthritis; vdH-S = van der Heijde-Sharp